Smith & Nephew SNATS (SNN) Competitors $30.26 +0.10 (+0.33%) As of 07/3/2025 03:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNN vs. GEHC, PHG, ZBH, SOLV, PEN, STVN, GKOS, NARI, IRTC, and TMDXShould you be buying Smith & Nephew SNATS stock or one of its competitors? The main competitors of Smith & Nephew SNATS include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. Smith & Nephew SNATS vs. Its Competitors GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Solventum Penumbra Stevanato Group Glaukos Inari Medical iRhythm Technologies TransMedics Group Smith & Nephew SNATS (NYSE:SNN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment. Which has better earnings & valuation, SNN or GEHC? GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS. Smith & Nephew SNATS is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmith & Nephew SNATS$5.81B2.28$412M$2.1614.01GE HealthCare Technologies$19.67B1.77$1.99B$4.7516.03 Is SNN or GEHC a better dividend stock? Smith & Nephew SNATS pays an annual dividend of $0.89 per share and has a dividend yield of 2.9%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew SNATS pays out 41.2% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years. Does the media prefer SNN or GEHC? In the previous week, GE HealthCare Technologies had 23 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 23 mentions for GE HealthCare Technologies and 0 mentions for Smith & Nephew SNATS. Smith & Nephew SNATS's average media sentiment score of 1.87 beat GE HealthCare Technologies' score of 1.33 indicating that Smith & Nephew SNATS is being referred to more favorably in the media. Company Overall Sentiment Smith & Nephew SNATS Very Positive GE HealthCare Technologies Positive Is SNN or GEHC more profitable? GE HealthCare Technologies has a net margin of 11.02% compared to Smith & Nephew SNATS's net margin of 0.00%. GE HealthCare Technologies' return on equity of 24.95% beat Smith & Nephew SNATS's return on equity.Company Net Margins Return on Equity Return on Assets Smith & Nephew SNATSN/A N/A N/A GE HealthCare Technologies 11.02%24.95%6.38% Do analysts recommend SNN or GEHC? Smith & Nephew SNATS currently has a consensus price target of $28.00, indicating a potential downside of 7.47%. GE HealthCare Technologies has a consensus price target of $88.27, indicating a potential upside of 15.93%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Smith & Nephew SNATS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smith & Nephew SNATS 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00GE HealthCare Technologies 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.83 Do insiders & institutionals believe in SNN or GEHC? 25.6% of Smith & Nephew SNATS shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 1.0% of Smith & Nephew SNATS shares are held by insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more volatility & risk, SNN or GEHC? Smith & Nephew SNATS has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. SummaryGE HealthCare Technologies beats Smith & Nephew SNATS on 16 of the 20 factors compared between the two stocks. Get Smith & Nephew SNATS News Delivered to You Automatically Sign up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNN vs. The Competition Export to ExcelMetricSmith & Nephew SNATSMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$13.26B$10.52B$5.56B$20.68BDividend Yield2.95%2.07%5.24%3.71%P/E Ratio14.0117.0327.6628.10Price / Sales2.2829.59415.1038.27Price / Cash9.5922.9936.8922.53Price / Book2.513.668.034.58Net Income$412M$235.40M$3.18B$986.06M7 Day Performance0.05%2.15%2.93%2.79%1 Month Performance-0.15%3.38%3.75%5.46%1 Year Performance12.87%-10.18%35.16%15.06% Smith & Nephew SNATS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNNSmith & Nephew SNATS3.7344 of 5 stars$30.26+0.3%$28.00-7.5%+20.4%$13.26B$5.81B14.0117,349GEHCGE HealthCare Technologies4.1345 of 5 stars$71.16-0.2%$88.27+24.0%-1.4%$32.64B$19.67B15.5053,000Positive NewsDividend AnnouncementPHGKoninklijke Philips3.6907 of 5 stars$22.67+1.7%N/A-7.1%$21.46B$19.50B52.7266,678ZBHZimmer Biomet4.9041 of 5 stars$91.51+0.3%$111.53+21.9%-12.1%$18.05B$7.68B11.5917,000News CoverageSOLVSolventum0.9323 of 5 stars$73.21-0.5%$80.29+9.7%+53.2%$12.73B$8.25B13.4722,000News CoveragePositive NewsAnalyst UpgradePENPenumbra4.7299 of 5 stars$254.41-1.0%$302.40+18.9%+41.2%$9.95B$1.19B78.084,500Insider TradeSTVNStevanato Group1.2454 of 5 stars€23.62+1.4%N/A+36.8%€7.15B€1.19B46.315,521News CoverageGKOSGlaukos4.5559 of 5 stars$96.80-3.3%$134.67+39.1%-13.2%$5.72B$383.48M-40.84780Positive NewsNARIInari MedicalN/A$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800IRTCiRhythm Technologies1.1841 of 5 stars$150.95+3.6%$138.60-8.2%+47.1%$4.65B$591.84M0.002,000Insider TradeTMDXTransMedics Group1.6162 of 5 stars$127.53+3.2%$127.33-0.2%-13.9%$4.18B$441.54M90.85210Positive News Related Companies and Tools Related Companies GE HealthCare Technologies Competitors Koninklijke Philips Competitors Zimmer Biomet Competitors Solventum Competitors Penumbra Competitors Stevanato Group Competitors Glaukos Competitors Inari Medical Competitors iRhythm Technologies Competitors TransMedics Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SNN) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smith & Nephew SNATS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smith & Nephew SNATS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
